ReviewOpen access rheumatology : research and reviews2023
Barriers to the Diagnosis of Early Inflammatory Arthritis: A Literature Review.
Review in Open access rheumatology : research and reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings.Rheumatology international · 2025Trial
- How do general practitioners diagnose and refer potential rheumatic musculoskeletal complaints? A scoping review.Clinical rheumatology · 2026Article
- First Contact Physiotherapists (FCPs) Referral Practices to Rheumatology: A Scoping Review of the Evidence Base.Musculoskeletal care · 2026Article
- Examining the Role of Wearables in Inflammatory Arthritis Care: A Narrative Literature Review.The Journal of rheumatology · 2026Review
- Machine learning improves online self-referral for inflammatory rheumatic diseases: a registry-based validation study.Rheumatology international · 2026Article
- Open-access clinic for arthralgia: patient flow and diagnostic pathways-a retrospective cohort study.EULAR rheumatology open · 2026Article
- Sociodemographic and economic barriers to initial specialist care for patients with rheumatoid arthritis: a scoping review.BMC rheumatology · 2025Article
- Exosomal Protein Biomarkers in Arthritis: Deciphering the Inflammatory Profiles of RA and OA.Biomedicines · 2025Article
- Trajectories of physical, mental health and health satisfaction before and after arthritis diagnosis: a UK population-based study.BMC musculoskeletal disorders · 2025Article
- Patient-Reported Outcomes of Depression and Fibromyalgia Symptoms Do Not Predict Non-Inflammatory versus Inflammatory Diagnoses at Initial Rheumatology Consultation.Healthcare (Basel, Switzerland) · 2024Article
- Prioritising Appointments by Telephone Interview: Duration from Symptom Onset to Appointment Request Predicts Likelihood of Inflammatory Rheumatic Disease.Journal of clinical medicine · 2024Article
- First contact physiotherapists: are they able to reduce the burden on rheumatology services? A critical review of the evidence base.Rheumatology advances in practice · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The early identification of patients with inflammatory arthritis and their referral to rheumatologists in order to establish a diagnosis and to start treatment plays a crucial role in patient outcomes. However, it is recognized that a large proportion of patients with inflammatory arthritis are diagnosed very late, losing the opportunity to start treatment in the very early stages of disease, resulting in a worse prognosis. This delay depends on several factors related to the patient, the disease, socio-demographic and health system aspects. Over time, several strategies have been developed and implemented at different levels aiming to overcome such barriers and to reduce the time from the onset of the symptoms until the diagnosis and start of adequate treatment. In this non-systematic comprehensive review, we will describe the main barriers in the identification of patients with inflammatory arthritis at different levels. We will also discuss the different strategies that have been implemented with the objective to overcome the recognized barriers and their impact in the reduction of delays.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.